Cigna Announces Enterprise Leadership Team for Combined Company
CEO David Cordani’s Leadership Team Will “Drive Improvements in Affordability, Choice and Quality for Customers and Clients; Sustained, Attractive Return for Shareholders”
Effective upon the Completion of the Express Scripts Merger, Expected by Year-End 2018
"This team is uniquely qualified to drive the improvements in affordability, choice and quality for our customers and clients, as well as the sustained attractive return for our shareholders, that this combination will deliver,” said
Upon closing, the combined company will offer multiple growth platforms:
- A commercial business, including employer-sponsored medical coverage,
- A government business, including Medicare offerings to seniors,
- An international business, including global supplemental benefits and
- A health services business, including
Express Scripts .
As previously announced,
Additionally, the following executives will be members of the combined company’s enterprise leadership team, reporting to
-
Lisa Bacus , Chief Marketing Officer -
Mark Boxer , Chief Information Officer -
Brian Evanko , President,U.S. Government Business -
Nicole Jones , General Counsel -
Matthew Manders , President, Strategy & Solutions - Dr.
Steven Miller , Chief Clinical Officer -
John Murabito , Chief Human Resources Officer -
Eric Palmer , Chief Financial Officer -
Jason Sadler , President, International Markets -
Michael Triplett , President,U.S. Commercial Business
Cigna and
Additional information is available at www.advancinghealthcare.com.
About Cigna
FORWARD LOOKING STATEMENTS
Information included or incorporated by reference in this communication, and information which may be contained in other filings with the
Forward-looking statements, including as they relate to
- the inability of
Express Scripts and Cigna to obtain regulatory approvals required for the merger or the requirement to accept conditions that could reduce the anticipated benefits of the merger as a condition to obtaining regulatory approvals; - the possibility that the anticipated benefits from the merger (including anticipated synergies) cannot be realized in full, or at all or may take longer to realize than expected;
- a longer time than anticipated to consummate the proposed merger;
- problems regarding the successful integration of the businesses of
Express Scripts and Cigna; - unexpected costs regarding the proposed merger;
- diversion of management's attention from ongoing business operations and opportunities;
- potential litigation associated with the proposed merger;
- the ability to retain key personnel;
- the availability of financing;
- effects on the businesses as a result of uncertainty surrounding the proposed merger;
- the ability of the combined company to achieve financial, strategic and operational plans and initiatives;
- the ability of the combined company to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers;
- the impact of modifications to the combined company's operations and processes;
- the ability of the combined company to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions;
- the substantial level of government regulation over the combined company's business and the potential effects of new laws or regulations or changes in existing laws or regulations;
- the outcome of litigation relating to the businesses of
Express Scripts and Cigna, regulatory audits, investigations, actions and/or guaranty fund assessments; - uncertainties surrounding participation in government-sponsored programs such as Medicare;
- the effectiveness and security of the combined company's information technology and other business systems;
- unfavorable industry, economic or political conditions, including foreign currency movements;
- acts of war, terrorism, natural disasters or pandemics; and
- the industry may be subject to future risks that are described in
SEC reports filed byExpress Scripts and Cigna.
You should carefully consider these and other relevant factors, including those risk factors in this communication and other risks and uncertainties that affect the businesses of
View source version on businesswire.com: https://www.businesswire.com/news/home/20180927005857/en/
860-902-4906
[email protected]
or
215-761-4198
[email protected]
Source:
PCS, LLC Expands Sales Team to Serve More Advisors in the Retirement Plan Business
Study: 100-Year Rain Events Will Strike Texas More Frequently
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News